An Information-Theoretic Analysis of Genetics, Gender and Age in Cancer Patients
Open Access
- 9 April 2008
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 3 (4) , e1951
Abstract
Germline genetics, gender and hormonal-signaling pathways are all well described modifiers of cancer risk and progression. Although an improved understanding of how germline genetic variants interact with other cancer risk factors may allow better prevention and treatment of human cancer, measuring and quantifying these interactions is challenging. In other areas of research, Information Theory has been used to quantitatively describe similar multivariate interactions. We implemented a novel information-theoretic analysis to measure the joint effect of a high frequency germline genetic variant of the p53 tumor suppressor pathway (MDM2 SNP309 T/G) and gender on clinical cancer phenotypes. This analysis quantitatively describes synergistic interactions among gender, the MDM2 SNP309 locus, and the age of onset of tumorigenesis in p53 mutation carriers. These results offer a molecular and genetic basis for the observed sexual dimorphism of cancer risk in p53 mutation carriers and a model is proposed that suggests a novel cancer prevention strategy for p53 mutation carriers.Keywords
This publication has 35 references indexed in Scilit:
- Relative performance of mutual information estimation methods for quantifying the dependence among short and noisy dataPhysical Review E, 2007
- MDM2 SNP309 Polymorphism as Risk Factor for Susceptibility and Poor Prognosis in Renal Cell CarcinomaClinical Cancer Research, 2007
- A Single Nucleotide Polymorphism in the MDM2 Gene Disrupts the Oscillation of p53 and MDM2 Levels in CellsCancer Research, 2007
- Association of a functional polymorphism in the promoter of the MDM2 gene with risk of nonsmall cell lung cancerInternational Journal of Cancer, 2006
- Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndromeJournal of Medical Genetics, 2005
- A Chromatin-associated and Transcriptionally Inactive p53-Mdm2 Complex Occurs in mdm2 SNP309 Homozygous CellsJournal of Biological Chemistry, 2005
- Improving cancer therapy by non-genotoxic activation of p53European Journal of Cancer, 2003
- Germline p53 Mutations in a Cohort with Childhood Sarcoma: Sex Differences in Cancer RiskThe American Journal of Human Genetics, 2003
- A New Recombinant Cell Bioassay for Ultrasensitive Determination of Serum Estrogenic Bioactivity in ChildrenThe Journal of Clinical Endocrinology & Metabolism, 2002
- A Unified Stepwise Regression Procedure for Evaluating the Relative Effects of Polymorphisms within a Gene Using Case/Control or Family Data: Application to HLA in Type 1 DiabetesThe American Journal of Human Genetics, 2002